Glubio Pharmaceutical Raises $50M Series A

Feb 28, 2022•over 3 years ago

Amount Raised

$50 Million

Round Type

series a

Description

GluBio Pharmaceutical has secured nearly $50 million in a Series A round of financing, bringing the total capital raised by the drugmaker to $70 million, it said in a statement on Monday.

Company Information

Company

Glu Bio Pharmaceutical

About

Proceeds from the financing will be used for tapping pipeline candidates, platform upgradation, and talent acquisition, the company said.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Glubio Pharmaceutical Raises $50M Series A

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information